All Title Author
Keywords Abstract

ISRN Oncology  2014 

Comparison of 3-Tier Cytological Grading Systems for Breast Carcinoma

DOI: 10.1155/2014/252103

Full-Text   Cite this paper   Add to My Lib


Background. Fine-needle aspiration cytology plays a major role in the primary diagnosis of breast carcinoma. Cytological grading of the smears can provide valuable prognostic information and aid in planning the management options. Aim. To evaluate various 3-tier cytological grading systems and to determine the best possible system which is reliable and objective for use in routine practice. Materials & Methods. 72 fine-needle aspiration smears of breast carcinomas were graded by two pathologists and compared with the histologic grading by Nottingham modification of Scarff-Bloom-Richardson method. Concordance and correlation studies were done. Kappa measurement of interobserver agreement was also done. Results. Robinson’s method showed a better correlation (77.7%) and substantial Kappa value of agreement with Bloom Richardson’s histological grading method in comparison to the other methods, closely followed by Fisher’s method. Fisher’s method showed better interobserver agreement (84.7%, ) compared to the other systems. Conclusions. Robinson’s method of cytological grading in fine-needle aspiration smears of breast carcinoma is simpler, multifactorial, and feasible, hence being preferable for routine use according to our study. 1. Introduction In India, breast cancer is the second most common malignancy in females, next to cervical cancer [1]. The study by Khanna et al. has shown increasing incidence in breast cancer, especially in the younger age group [2]. Early diagnosis and prompt therapy are important to increase the survival of the patients. Surgical biopsy specimens serve as the “gold standard” for validating the diagnostic criteria and the value of histological grading has been widely accepted [3]. Fine needle aspiration (FNA) cytology is used for the preoperative diagnosis of breast malignancies and its role in determining the prognosis is being studied by various authors. The National Cancer Institute, Bethesda, sponsored conference had also recommended that the tumour grading on FNA material should be incorporated in FNA reports for prognostication [4]. Black et al. in 1955 introduced the concept of nuclear grading, which was modified and applied in cytological smears by Fisher et al. [5, 6]. Numerous two-tier and three-tier systems have been proposed for the cytological grading of breast tumors, but no single system is currently adapted for use in the routine evaluation of cytological aspirates of breast carcinoma. In the present study, various three-tier cytological grading systems were studied and compared to arrive at a simple, effective,


[1]  A. K. Patra, R. N. Mallik, and S. Dash, “Fine needle aspiration as a primary diagnostic procedure of breast lumps,” Indian Journal of Pathology and Microbiology, vol. 34, no. 4, pp. 259–264, 1991.
[2]  R. Khanna, S. Khanna, S. Chaturvedi, and N. C. Arya, “Spectrum of breast disease in young females: a retrospective study of 1315 patients,” Indian Journal of Pathology and Microbiology, vol. 41, no. 4, pp. 397–401, 1998.
[3]  S. P. Meena, D. K. Hemrajani, and N. Joshi, “A comparative and evaluative study of cytological and histological grading system profile in malignant neoplasm of breast: an important prognostic factor,” Indian Journal of Pathology and Microbiology, vol. 49, no. 2, pp. 199–202, 2006.
[4]  A. Abati, J. Abele, S. S. Bacus, et al., “The uniform approach to breast fine-needle aspiration biopsy,” Diagnostic Cytopathology, vol. 16, pp. 295–311, 1997.
[5]  M. M. Black, S. R. Opler, and F. D. Speer, “Survival in breast cancer cases in relation to the structure of the primary tumour ad regional lymph nodes,” Surgery, Gynecology and Obstetrics, vol. 100, pp. 543–551, 1955.
[6]  E. R. Fisher, R. M. Gregorio, and B. Fisher, “The pathology of invasive breast cancer: a syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4),” Cancer, vol. 36, no. 1, pp. 1–85, 1975.
[7]  I. A. Robinson, G. McKee, A. Nicholson et al., “Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas,” The Lancet, vol. 343, no. 8903, pp. 947–949, 1994.
[8]  I. Robinson and G. McKee, “Cytologic grading of breast carcinoma,” Acta Cytologica, vol. 39, no. 6, p. 1257, 1995.
[9]  D. J. Dabbs and J. F. Silverman, “Prognostic factors from the fine-needle aspirate: breast carcinoma nuclear grade,” Diagnostic Cytopathology, vol. 10, no. 3, pp. 203–208, 1994.
[10]  M. Z. Khan, A. Haleem, H. Al Hassani, and H. Kfoury, “Cytopathological grading, as a predictor of histopathological grade, in ductal carcinoma (NOS) of breast, on air-dried diff-quik smears,” Diagnostic Cytopathology, vol. 29, no. 4, pp. 185–193, 2003.
[11]  E. Taniguchi, Q. Yang, W. Tang et al., “Cytologic grading of invasive breast carcinoma: correlation with clinicopathologic variables and predictive value of nodal metastasis,” Acta Cytologica, vol. 44, no. 4, pp. 587–591, 2000.
[12]  J. Mouriquand and D. Pasquier, “Fine needle aspiration of breast carcinoma: a preliminary cytoprognostic study,” Acta Cytologica, vol. 24, no. 2, pp. 153–159, 1980.
[13]  L. P. Howell, R. Gandour-Edwards, and D. O'Sullivan, “Application of the Scarff-Bloom-Richardson tumor grading system to fine-needle aspirates of the breast,” The American Journal of Clinical Pathology, vol. 101, no. 3, pp. 262–265, 1994.
[14]  C. W. Elston and I. O. Ellis, “Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up,” Histopathology, vol. 19, no. 5, pp. 403–410, 1991.
[15]  V. Bhargava, M. Jain, K. Agarwal, S. Thomas, and S. Singh, “Critical appraisal of cytological nuclear grading in carcinoma of the breast and its correlation with ER/PR expression,” Journal of Cytology, vol. 25, no. 2, pp. 58–61, 2008.
[16]  J. A. Zoppi, E. M. Pellicer, and A. S. Sundblad, “Cytohistologic correlation of nuclear grade in breast carcinoma,” Acta Cytologica, vol. 41, no. 3, pp. 701–704, 1997.
[17]  K. Saha, G. Raychaudhuri, B. K. Chattopadhyay, and I. Das, “Comparative evaluation of six cytological grading systems in breast carcinoma,” Journal of Cytology, vol. 30, pp. 87–93, 2013.
[18]  A. K. Das, K. Kapila, A. K. Dinda, and K. Verma, “Comparative evaluation of grading of breast carcinomas in fine needle aspirates by two methods,” Indian Journal of Medical Research, vol. 118, pp. 247–250, 2003.
[19]  S. Chhabra, P. K. Singh, A. Agarwal, A. Bhagoliwal, and S. N. Singh, “Cytological grading of breast carcinoma: a multivariate regression analysis,” Journal of Cytology, vol. 22, article 2, 2005.
[20]  N. Khan, N. Afroz, F. Rana, and M. A. Khan, “Role of cytologic grading in prognostication of invasive breast carcinoma,” Journal of Cytology, vol. 26, no. 2, pp. 65–68, 2009.
[21]  S. Sinha, N. Sinha, R. Bandyopadhyay, and S. Mondal, “Robinson's cytological grading on aspirates of breast carcinoma: correlation with Bloom Richardson's histological grading,” Journal of Cytology, vol. 26, no. 4, pp. 140–143, 2009.
[22]  J. B. Lingegowda, P. H. Muddegowda, C. K. Ramakantha, and H. R. Chandrasekar, “Cytohistological correlation of grading in breast carcinoma,” Diagnostic Cytopathology, vol. 39, no. 4, pp. 251–257, 2011.
[23]  L. W. Dalton, D. L. Page, and W. D. Dupont, “Histologic grading of breast carcinoma: a reproducibility study,” Cancer, vol. 73, pp. 2765–2770, 1994.


comments powered by Disqus

Contact Us


微信:OALib Journal